IBD Stock Of The Day: Jazz Pharma Approaches Buy Point Ahead Of Earnings
Jazz Pharmaceuticals is the IBD Stock Of The Day as the pharmaceutical company approaches a buy point ahead of its second-quarter report next week. Shares are forming a flat base with a buy point at 184.10